Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIFLURIDINE for Rectal cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 11 adverse event reports in the FDA FAERS database where TRIFLURIDINE was used for Rectal cancer.

Most Reported Side Effects for TRIFLURIDINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 34 19.7% 1 10
Death 21 12.1% 21 1
Neutropenia 21 12.1% 1 6
Colorectal cancer metastatic 16 9.3% 10 1
Condition aggravated 16 9.3% 0 12
Diarrhoea 16 9.3% 1 6
Covid-19 15 8.7% 7 1
Drug resistance 15 8.7% 0 8
Anaemia 14 8.1% 1 1
Disease progression 14 8.1% 2 6
Fatigue 12 6.9% 1 2
Eye irritation 11 6.4% 0 0
Pathogen resistance 11 6.4% 0 7
General physical health deterioration 10 5.8% 7 1
Nausea 10 5.8% 1 4

Other Indications for TRIFLURIDINE

Product used for unknown indication (39) Colorectal cancer metastatic (28) Ophthalmic herpes simplex (18) Rectal adenocarcinoma (9) Colorectal cancer (6) Herpes ophthalmic (6) Chemotherapy (5) Eye infection (5)

Other Drugs Used for Rectal cancer

CAPECITABINE (2,976) OXALIPLATIN (2,402) FLUOROURACIL (1,610) BEVACIZUMAB (1,546) TIPIRACIL\TRIFLURIDINE (1,297) IRINOTECAN (985) LEUCOVORIN (660) CETUXIMAB (542) REGORAFENIB (505) PANITUMUMAB (374)

Related Pages

TRIFLURIDINE Full Profile All Rectal cancer Drugs TRIFLURIDINE Demographics TRIFLURIDINE Timeline